We have located links that may give you full text access.
Salbutamol increases leg glucose uptake and metabolic rate but not muscle glycogen resynthesis in recovery from exercise.
Journal of Clinical Endocrinology and Metabolism 2021 October 20
CONTENT: Exercise blunts the effect of beta2-agonist on peripheral glucose uptake and energy expenditure. Whether such attenuation extends into recovery is unknown.
OBJECTIVE: To examine the effect of beta2-agonist on leg glucose uptake and metabolic rate in recovery from exercise.
DESIGN: Using leg arteriovenous balance technique and analyses of thigh muscle biopsies, we investigated the effect of beta2-agonist (24 mg oral salbutamol) versus placebo on leg glucose, lactate, and oxygen exchange before, during, and 0.5-5-h in recovery from quadriceps exercise, as well as on muscle glycogen resynthesis and activity in recovery.
PARTICIPANTS: Twelve healthy lean young men.
RESULTS: Before exercise, leg glucose uptake was 0.42±0.12 and 0.20±0.02 mmol×min -1 (mean±SD) for salbutamol and placebo (P=0.06), respectively, while leg oxygen consumption was around two-fold higher (P<0.01) for salbutamol than placebo (25±3 versus 14±1 mL×min -1). No treatment differences were observed in leg glucose uptake, lactate release, and oxygen consumption during exercise. But in recovery, cumulated leg glucose uptake, lactate release, and oxygen consumption was 21 mmol (95%CI: 18-24, P=0.018), 19 mmol (95%CI: 16-23, P<0.01), and 1.8 L (95%CI: 1.6-2.0, P<0.01) higher for salbutamol than placebo, respectively. Muscle glycogen content was around 30% lower (P<0.01) for salbutamol than placebo in recovery, whereas no treatment differences were observed in muscle glycogen resynthesis or glycogen synthase activity.
CONCLUSIONS: Exercise blunts the effect of beta2-agonist on leg glucose uptake, but this attenuation diminishes in recovery. Beta2-agonist increases leg lactate release in recovery, which may relate to glycolytic trafficking due to excessive myocellular glucose uptake.
OBJECTIVE: To examine the effect of beta2-agonist on leg glucose uptake and metabolic rate in recovery from exercise.
DESIGN: Using leg arteriovenous balance technique and analyses of thigh muscle biopsies, we investigated the effect of beta2-agonist (24 mg oral salbutamol) versus placebo on leg glucose, lactate, and oxygen exchange before, during, and 0.5-5-h in recovery from quadriceps exercise, as well as on muscle glycogen resynthesis and activity in recovery.
PARTICIPANTS: Twelve healthy lean young men.
RESULTS: Before exercise, leg glucose uptake was 0.42±0.12 and 0.20±0.02 mmol×min -1 (mean±SD) for salbutamol and placebo (P=0.06), respectively, while leg oxygen consumption was around two-fold higher (P<0.01) for salbutamol than placebo (25±3 versus 14±1 mL×min -1). No treatment differences were observed in leg glucose uptake, lactate release, and oxygen consumption during exercise. But in recovery, cumulated leg glucose uptake, lactate release, and oxygen consumption was 21 mmol (95%CI: 18-24, P=0.018), 19 mmol (95%CI: 16-23, P<0.01), and 1.8 L (95%CI: 1.6-2.0, P<0.01) higher for salbutamol than placebo, respectively. Muscle glycogen content was around 30% lower (P<0.01) for salbutamol than placebo in recovery, whereas no treatment differences were observed in muscle glycogen resynthesis or glycogen synthase activity.
CONCLUSIONS: Exercise blunts the effect of beta2-agonist on leg glucose uptake, but this attenuation diminishes in recovery. Beta2-agonist increases leg lactate release in recovery, which may relate to glycolytic trafficking due to excessive myocellular glucose uptake.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app